Neuromyelitis optica IgG causes placental inflammation and fetal death.

Neuromyelitis optica IgG causes placental inflammation and fetal death.

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the CNS and affects women of childbearing age. Most patients with NMO have circulating Abs, termed NMO-IgG, against the astrocytic water channel protein aquaporin-4. In the CNS, NMO-IgG causes complement-mediated astrocyte damage...

Полное описание

Библиографические подробности
Главные авторы:	Saadoun, S, Waters, P, Leite, M, Bennett, J, Vincent, A, Papadopoulos, M
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
по: Saadoun, S, и др.
Опубликовано: (2013)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
по: Saadoun, S, и др.
Опубликовано: (2013)

NMO-IgG in the diagnosis of neuromyelitis optica.
по: Jarius, S, и др.
Опубликовано: (2007)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
по: Saadoun, S, и др.
Опубликовано: (2010)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
по: Akman-Demir, G, и др.
Опубликовано: (2008)

Seroprevalence of Neuromyelitis Optica-IgG of Childhood Compared to Adults
по: J Gordon Millichap
Опубликовано: (2008-02-01)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
по: Kim, S, и др.
Опубликовано: (2011)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
по: Jacob, S, и др.
Опубликовано: (2008)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
по: Littleton, E, и др.
Опубликовано: (2006)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
по: Narayanan Unni, и др.
Опубликовано: (2013-01-01)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
по: Jarius, S, и др.
Опубликовано: (2007)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
по: Min, J, и др.
Опубликовано: (2010)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
по: Jacob, S, и др.
Опубликовано: (2007)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
по: Jarius, S, и др.
Опубликовано: (2007)

Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders
по: Shiyu Gao, и др.
Опубликовано: (2024-03-01)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
по: Saadoun, S, и др.
Опубликовано: (2012)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.
по: Saadoun, S, и др.
Опубликовано: (2012)

Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica Soroprevalência do anticorpo NMO-IgG em pacientes brasileiros com neuromielite óptica
по: Tarso Adoni, и др.
Опубликовано: (2008-06-01)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
по: Lukmanee Tradtrantip, и др.
Опубликовано: (2021-11-01)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
по: Tianjiao Duan, и др.
Опубликовано: (2018-10-01)

Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder
по: Eun Bin Cho, и др.
Опубликовано: (2024-03-01)

Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks
по: Edouard Januel, и др.
Опубликовано: (2024-01-01)

Dried blood spot improves global access to aquaporin‐4‐IgG testing for neuromyelitis optica
по: Nisa Vorasoot, и др.
Опубликовано: (2024-11-01)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
по: Felix A. Schmidt, и др.
Опубликовано: (2020-09-01)

CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
по: Lukmanee Tradtrantip, и др.
Опубликовано: (2019-03-01)

Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
по: Oliver Schmetzer, и др.
Опубликовано: (2021-03-01)

Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis
по: Li Xu, и др.

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder
по: Zhichao Li, и др.
Опубликовано: (2023-01-01)

Orbital Ectopic Lymphoid Follicles with Germinal Centers in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders
по: Koon Ho Chan, и др.
Опубликовано: (2018-01-01)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
по: Waters, P, и др.
Опубликовано: (2015)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
по: Jarius, S, и др.
Опубликовано: (2007)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
по: Papadopoulos, M, и др.
Опубликовано: (2011)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
по: Tianjiao Duan, и др.
Опубликовано: (2019-07-01)

Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
по: Alvaro Cobo-Calvo, и др.
Опубликовано: (2020-01-01)

Neuromyelitis Optica with NMO-IgG/ Anti-AQP4 Antibody Positive: First Case Reported from Uttarakhand India
по: Manish Mittal, и др.
Опубликовано: (2014-07-01)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
по: Jacob, A, и др.
Опубликовано: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
по: Viegas, S, и др.
Опубликовано: (2009)

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
по: Saadoun, S, и др.
Опубликовано: (2011)

Complement activation in patients with neuromyelitis optica
по: Nytrova, P, и др.
Опубликовано: (2014)

Complement activation in patients with neuromyelitis optica.
по: Nytrova, P, и др.
Опубликовано: (2014)